Bart van Rhijn
Direttore Finanziario/CFO presso NANOBIOTIX
Patrimonio netto: - $ in data 30/04/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Enno Spillner | M | 55 | 10 anni | |
Laurent Lévy | M | 53 | 21 anni | |
Anne-Marie Graffin | F | 63 | 10 anni | |
Gary Phillips | M | 58 | 3 anni | |
Louis Kayitalire | M | 66 | 1 anni | |
Alain Herrera | M | 74 | 13 anni | |
Patrick Tricoli | M | - | 10 anni | |
Anne-Juliette Hermant | F | 51 | 5 anni | |
Brandon Owens | M | - | - | |
Margaret Galluzzi | F | - | 5 anni | |
Mariam Hamze | F | 41 |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | 6 anni |
Craig West | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Philippe Mauberna | M | 59 | 8 anni | |
Raffaele Baffa | M | 65 |
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company is based in Boston, MA. Servier Pharmaceuticals continues to build a treatment portfolio with a current focus on oncology within acute lymphoblastic leukemia. The company invests in innovative research and development through development or partnerships to best address the unmet needs of patients. Additionally, the company is proud to offer financial assistance to not only support patients and their families but a variety of focused advocacy groups and healthcare professionals as well. Servier Pharmaceuticals is committed to engaging with patients, caregivers, families, and patient organizations to ensure their voices are heard in every initiative. The company's responsibility is to help make the world a better place for patients and their families, and it strives to have consistent and concise transparency throughout all clinical trials and research and development for the benefit of all patients. The company was founded in 1954. The CEO is David K. Lee. | 2 anni |
Leonard A. Farber | M | - | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Francia | 14 | 93.33% |
Stati Uniti | 1 | 6.67% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Bart van Rhijn
- Contatti personali